Related Experiment Video
Updated: May 5, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Comment on "Prognostic Performance of Model for End-Stage Liver Disease (MELD) 3.0 for Transjugular Intrahepatic
Tanjima Tarique Laskar1, Sudarshana Borah2, Monica Arora3
1School of Pharmaceutical Sciences, University of Science and Technology Meghalaya, Techno City, Meghalaya, India.
Abstract:
Michimoto et al. demonstrated superior prognostic performance of MELD 3.0 for elective TIPS. While findings support improved risk stratification, lack of data on patients not undergoing TIPS and exclusion of key clinical outcomes limit immediate applicability. Broader validation and inclusion of post-TIPS complications are needed to guide patient selection and treatment decisions effectively.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

